Tosoh Bioscience - Diagnostics EMEA has launched the AIA®-CL300, its new compact automated chemiluminescent enzyme immunoassay analyzer. This “small giant” - as it is promoted - is the perfect instrument for small to large laboratories to perform routine analysis, cover emergency use, run specific pathologies and esoteric tests and enhance assay analytical specifications. The AIA-CL300 benefits from the sensitivity, and analytical performances of the AIA-CL technology range with improved ease of use.
The new AIA-CL300 desktop device can run as well in small laboratories as the large ones thanks to its compact size (660 mm height, 640 mm depth and 520 mm width). In terms of usability, its digital touch screen in full colour allows a better visibility to check the inventory of substrate, washer, and diluent which are easily accessible in front compartments of the instrument. The intuitive ‘One-Touch’ Assay Start, a detector standardization cup (STD cup), eases the daily check process. All these features facilitate the use for the operators and help to prevent human errors.
The AIA-CL300, depending on the assay, promises to deliver results between 15 minutes (for most analytes) to 35 minutes with a maximum throughput of 30 tests/hour. Its integrated quality control program with an error-free program automatically checks if reagent cup corresponds to test required. Its advanced technology and automation processes (auto sample dilution, auto pre-treatment, auto adjuster reconstitution) reduce manual operation and improve laboratory and diagnostic efficiency leading to better patient outcomes and treatments.
One unique feature that characterizes the AIA-CL systems is the 1 cup = 1 test concept. This means that all the specific reagents, required to perform one test, are contained inside one cup in a lyophilised form, offering predictable consumption, 90-days calibration stability for all assays, a good traceability of all samples and data.
“AIA-CL300 is designed to produce high quality results 24/7. Its advanced technology and automation processes, improve workflows and turnaround time, reduce hands-on-time, prevent operator introduced variability and improve laboratory and diagnostic efficiency leading to better patient outcomes and treatments”, emphasized Dr. Dimitrios Giantzoudis, Senior Product Manager, Tosoh Bioscience – Diagnostics EMEA.Want the latest science news straight to your inbox? Become a SelectScience member for free today >>